https://t.co/agALLgxCQ6

For autoimmune disease, this does work.IL-6 antibodies used in rheumatoid arthritis lower Lp(a) ~30%, but it goes back to its generically determined baseline and may still be elevated. https://t.co/UwZxVlIlVk

here are some papers to help with the answers: 1- https://t.co/MjSAq6IygK 2- https://t.co/DboO731QGj 3- https://t.co/p6fBFrybwS 4- https://t.co/UwZxVlqcHc

RT @Lpa_Doc: 13/18 3-If a patient has chronic inflammation (i.e rheumatoid arthritis) Lp(a) can be ~30% higher than baseline. We know this…

RT @Lpa_Doc: 13/18 3-If a patient has chronic inflammation (i.e rheumatoid arthritis) Lp(a) can be ~30% higher than baseline. We know this…

13/18 3-If a patient has chronic inflammation (i.e rheumatoid arthritis) Lp(a) can be ~30% higher than baseline. We know this because if these patients are treated with anti-IL-6 antibodies their Lp(a) goes down 30%- https://t.co/UwZxVlqcHc

RT @gerdosi: In line with the above, pharmacological IL-6 blockade for ~3 months almost halved Lp(a) level in RA patients. https://t.co/RbN…

Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseasesi https://t.co/LuaIWV52p1

In line with the above, pharmacological IL-6 blockade for ~3 months almost halved Lp(a) level in RA patients. https://t.co/RbNJ4ZxjWi